References of "Dispas, Marc"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailEstimation du coût global d'un plan de lutte contre l'IBR en Belgique
Dispas, Marc; Houtain, Jean Yves; Muylkens, Benoît ULg et al

in Epidémiologie et Santé Animale (2006), 49

Detailed reference viewed: 9 (4 ULg)
Full Text
Peer Reviewed
See detailGenetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8.
Toussaint, Jean-Francois; Coen, Laurent; Letellier, Carine et al

in Veterinary Research (2005), 36(4), 529-44

Bovine herpesvirus 1 (BoHV-1) has frequently been used as a model for testing parameters affecting DNA immunisation in large animals like cattle. However, the selection of target antigens has been poorly ... [more ▼]

Bovine herpesvirus 1 (BoHV-1) has frequently been used as a model for testing parameters affecting DNA immunisation in large animals like cattle. However, the selection of target antigens has been poorly studied, and most of the experiments have been conducted in mice. In the present study, we demonstrated in cattle that a DNA vaccine encoding BoHV-1 glycoprotein gD induces higher neutralising antibody titres than vaccines encoding BoHV-1 gC. Additionally, we show that a DNA vaccine encoding a secreted form of gD induces a higher immune response than a vaccine encoding full-length gD. However, the enhanced immunogenicity associated with the secretion of gD could not be extended to the glycoprotein gC. The current study also describes for the first time the development and the evaluation of a DNA vaccine encoding the major tegument protein VP8. This construct, which is the first BoHV-1 plasmid vaccine candidate that is not directed against a surface glycoprotein, induced a high BoHV-1 specific cellular immunity but no humoral immune response. The calves vaccinated with the constructs encoding full-length and truncated gD showed a non-significant tenfold reduction of virus excretion after challenge. Those calves also excreted virus for significantly (p < 0.05) shorter periods (1.5 days) than the non-vaccinated controls. The other constructs encoding gC and VP8 antigens induced no virological protection as compared to controls. Altogether the DNA vaccines induced weaker immunity and protection than conventional marker vaccines tested previously, confirming the difficulty to develop efficient DNA vaccines in large species. [less ▲]

Detailed reference viewed: 16 (7 ULg)
Full Text
Peer Reviewed
See detailEstimation de la prévalence réelle de l'encéphalopathie spongiforme bovine en Belgique en 2002 et 2003
Penders, Julie; Praet, Nicolas; Berckvens, D. et al

in Epidémiologie et Santé Animale (2005), 47

Detailed reference viewed: 10 (4 ULg)
Full Text
Peer Reviewed
See detailLes conséquences de l'infection des bovins par le virus de la rhinotrachéite infectieuse bovine
Thiry, Etienne ULg; Lemaire, Mylène; Schynts, Frédéric et al

in Point Vétérinaire (1999), 30

Detailed reference viewed: 11 (2 ULg)
Full Text
See detailLe rôle de la vaccination dans la prévention des maladies respiratoires d'origine virale chez les bovins
Thiry, Etienne ULg; Pastoret, Paul-Pierre ULg; Dispas, Marc et al

in Les troubles respiratoires des bovins, synthèse à partir de cas concrets (1997)

Detailed reference viewed: 22 (1 ULg)
Full Text
Peer Reviewed
See detailLes différents vaccins disponibles contre la rhinotrachéite infectieuse bovine
Thiry, Etienne ULg; Lemaire, Mylène; Schynts, Frédéric et al

in Bulletin des Groupements Techniques Vétérinaires (1997), 4B

Detailed reference viewed: 7 (0 ULg)
Full Text
Peer Reviewed
See detailLa rhinotrachéite infectieuse bovine : caractéristiques du virus, l'infection et ses manifestations cliniques
Thiry, Etienne ULg; Lemaire, Mylène; Vanderheijden, Nathalie et al

in Bulletin des Groupements Techniques Vétérinaires (1997), 568

Detailed reference viewed: 13 (2 ULg)